 Muscle Relaxants, Central
"Muscle Relaxants, Central" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)
| Descriptor ID |
D009125
|
| MeSH Number(s) |
D27.505.696.510 D27.505.696.663.700.600 D27.505.954.427.525
|
| Concept/Terms |
Muscle Relaxants, Central- Muscle Relaxants, Central
- Central Muscle Relaxants
- Relaxants, Central Muscle
- Centrally Acting Muscle Relaxants
|
Below are MeSH descriptors whose meaning is more general than "Muscle Relaxants, Central".
Below are MeSH descriptors whose meaning is more specific than "Muscle Relaxants, Central".
This graph shows the total number of publications written about "Muscle Relaxants, Central" by people in this website by year, and whether "Muscle Relaxants, Central" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Muscle Relaxants, Central" by people in Profiles.
-
Killam-Worrall L, Brand R, Castro JR, Patel DS, Huynh K, Lindley B, Torres BP. Baclofen and Tizanidine Adverse Effects Observed Among Community-Dwelling Adults Above the Age of 50 Years: A Systematic Review. Ann Pharmacother. 2024 May; 58(5):523-532.
-
Xu AL, Marrache M, Hardesty CK, Groves ML, Erickson MA, Murphy RF, Thompson GH, Sponseller PD. Baclofen Pump Use: Complications After Growth-friendly Instrumentation for Early-onset Scoliosis. J Pediatr Orthop. 2022 Feb 01; 42(2):77-82.
-
Mohon RT, Sawyer K, Pickett K, Bothwell S, Brinton JT, Sobremonte-King M, DelRosso LM. Sleep-related breathing disorders associated with intrathecal baclofen therapy to treat patients with cerebral palsy: A cohort study and discussion. NeuroRehabilitation. 2021; 48(4):481-491.
-
Farkhondeh T, Roshanravan B, Shirazi FM, Mehrpour O. Can dantrolene be used in the treatment of cardioglycosides poisonings? Expert Opin Drug Metab Toxicol. 2021 Jan; 17(1):1-2.
-
Litman RS, Smith VI, Larach MG, Mayes L, Shukry M, Theroux MC, Watt S, Wong CA. Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia. Anesth Analg. 2019 04; 128(4):652-659.
-
Larach MG, Klumpner TT, Brandom BW, Vaughn MT, Belani KG, Herlich A, Kim TW, Limoncelli J, Riazi S, Sivak EL, Capacchione J, Mashman D, Kheterpal S, Kooij F, Wilczak J, Soto R, Berris J, Price Z, Lins S, Coles P, Harris JM, Cummings KC, Berman MF, Nanamori M, Adelman BT, Wedeven C, LaGorio J, McCormick PJ, Tom S, Aziz MF, Coffman T, Ellis TA, Molina S, Peterson W, Mackey SC, van Klei WA, Ginde AA, Biggs DA, Neuman MD, Craft RM, Pace NL, Paganelli WC, Durieux ME, Nair BJ, Wanderer JP, Miller SA, Helsten DL, Turnbull ZA, Schonberger RB. Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review. Anesthesiology. 2019 01; 130(1):41-54.
-
Hillman L, Yadlapati R, Thuluvath AJ, Berendsen MA, Pandolfino JE. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease. Dis Esophagus. 2017 Sep 01; 30(9):1-15.
-
Muehlschlegel S, Carandang R, Hall W, Kini N, Izzy S, Garland B, Ouillette C, van der Bom IM, Flood TF, Gounis MJ, Weaver JP, Barton B, Wakhloo AK. Dantrolene for cerebral vasospasm after subarachnoid haemorrhage: a randomised double blind placebo-controlled safety trial. J Neurol Neurosurg Psychiatry. 2015 Sep; 86(9):1029-35.
-
Varhabhatla NC, Zuo Z. Rising complication rates after intrathecal catheter and pump placement in the pediatric population: analysis of national data between 1997 and 2006. Pain Physician. 2012 Jan-Feb; 15(1):65-74.
-
Menard-Katcher C, Henretig FM, Osterhoudt KC. A 19-month-old girl with recurrent illness: over the hills and through the woods. Pediatr Emerg Care. 2009 Dec; 25(12):869-71.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|